-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Cingulate (NASDAQ:CING) Shares Down 10.8%
Cingulate (NASDAQ:CING) Shares Down 10.8%
Shares of Cingulate Inc. (NASDAQ:CING – Get Rating) were down 10.8% during mid-day trading on Monday . The stock traded as low as $0.90 and last traded at $0.95. Approximately 151,205 shares changed hands during mid-day trading, an increase of 20% from the average daily volume of 126,455 shares. The stock had previously closed at $1.06.
Analyst Ratings Changes
Several equities research analysts recently commented on CING shares. Ascendiant Capital Markets initiated coverage on Cingulate in a report on Monday, October 3rd. They issued a "buy" rating for the company. Maxim Group initiated coverage on Cingulate in a report on Tuesday, November 22nd. They issued a "buy" rating on the stock.
Get Cingulate alerts:Cingulate Stock Performance
The company has a market cap of $10.69 million and a P/E ratio of -0.64. The business's fifty day moving average is $0.97 and its two-hundred day moving average is $1.23.
Cingulate (NASDAQ:CING – Get Rating) last posted its quarterly earnings data on Monday, November 14th. The company reported ($0.36) EPS for the quarter.Insider Activity at Cingulate
In related news, Director Peter J. Werth bought 28,934 shares of the company's stock in a transaction dated Tuesday, December 13th. The shares were acquired at an average price of $0.98 per share, for a total transaction of $28,355.32. Following the completion of the transaction, the director now directly owns 975,165 shares in the company, valued at $955,661.70. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, Director Gregg Wm Givens purchased 85,000 shares of Cingulate stock in a transaction dated Tuesday, November 22nd. The shares were purchased at an average price of $0.88 per share, with a total value of $74,800.00. Following the transaction, the director now owns 154,318 shares in the company, valued at $135,799.84. The purchase was disclosed in a document filed with the SEC, which is available through this link. Also, Director Peter J. Werth bought 28,934 shares of the business's stock in a transaction on Tuesday, December 13th. The stock was purchased at an average cost of $0.98 per share, for a total transaction of $28,355.32. Following the transaction, the director now owns 975,165 shares of the company's stock, valued at $955,661.70. The disclosure for this purchase can be found here. Insiders bought a total of 141,388 shares of company stock worth $129,998 in the last three months. Company insiders own 31.28% of the company's stock.
Hedge Funds Weigh In On Cingulate
A number of institutional investors and hedge funds have recently modified their holdings of CING. Eagle Asset Management Inc. lifted its stake in Cingulate by 124.5% in the third quarter. Eagle Asset Management Inc. now owns 107,527 shares of the company's stock valued at $115,000 after buying an additional 59,632 shares during the last quarter. Renaissance Technologies LLC acquired a new position in Cingulate during the first quarter worth $100,000. Finally, Creative Planning acquired a new position in Cingulate during the second quarter worth $34,000. Institutional investors and hedge funds own 2.35% of the company's stock.
About Cingulate
(Get Rating)
Cingulate Inc, a clinical-stage biopharmaceutical company, focuses on the development of product candidates for the treatment of attention-deficit/hyperactivity disorder. The company's lead product candidates are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, and CTx-1302 (dextroamphetamine) for the treatment of attention-deficit/hyperactivity disorders.
Read More
- Get a free copy of the StockNews.com research report on Cingulate (CING)
- 3 Airline Stocks Taking Off in 2023
- Why Wall Street Has Bullish Targets on Target Stock
- What Macy's Guidance Means For Retail
- Fortinet Stock Price Bumpy, Here Is Why
- Apexigen Stock Soars After Analyst Rating, Is It Time to Buy?
Receive News & Ratings for Cingulate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cingulate and related companies with MarketBeat.com's FREE daily email newsletter.
纳斯达克股价周一午盘下跌10.8%。该股交易价格低至0.90美元,最新报0.95美元。午盘交易中,约有151,205股易手,较126,455股的日均成交量增加了20%。该股此前收盘价为1.06美元。
分析师评级发生变化
几位股票研究分析师最近对CING的股票发表了评论。Ascaldiant Capital Markets在10月3日星期一的一份报告中发起了对cingate的报道。他们对该公司的评级为“买入”。Maxim Group在11月22日星期二的一份报告中发起了对cingate的报道。他们对该股的评级为“买入”。
到达扣带状警报:盘算股票表现
该公司市值为1,069万美元,市盈率为-0.64。该业务的50日移动均线切入位为0.97美元,200日移动均线切入位为1.23美元。
纳斯达克(纳斯达克代码:Cing-Get Rating)上一次公布季度收益数据是在11月14日(星期一)。该公司公布了该季度每股收益(0.36美元)。Cingate的内幕活动
在相关新闻中,董事彼得·韦斯在一笔日期为12月13日(星期二)的交易中购买了28,934股该公司股票。这些股票是以每股0.98美元的平均价格收购的,总交易额为28,355.32美元。交易完成后,董事现在直接拥有该公司975,165股,价值955,661.70美元。这笔交易是在提交给美国证券交易委员会的一份文件中披露的,该文件可以通过美国证券交易委员会网站。其他新闻方面,董事Gregg Wm Givens在一笔日期为11月22日(星期二)的交易中购买了85,000股彩虹股票。这些股票是以每股0.88美元的平均价格购买的,总价值为74,800.00美元。交易完成后,董事现在拥有该公司154,318股股份,价值135,799.84美元。此次收购是在提交给美国证券交易委员会的一份文件中披露的,该文件可通过这个环节。此外,董事彼得·J·韦斯在12月13日(星期二)的一次交易中购买了28,934股该公司的股票。这只股票是以每股0.98美元的平均成本购买的,总交易额为28,355.32美元。交易完成后,董事现在拥有975,165股该公司股票,价值955,661.70美元。关于这次购买的披露可以找到这里。在过去的三个月里,内部人士总共购买了141,388股公司股票,价值129,998美元。公司内部人士持有该公司31.28%的股份。
对冲基金参与扣带交易
多家机构投资者和对冲基金最近调整了对CING的持股。Eagle Asset Management Inc.在第三季度增持了124.5%的Cingate股份。Eagle Asset Management Inc.现在持有107,527股该公司股票,价值11.5万美元,该公司在上个季度又购买了59,632股。复兴科技有限责任公司在第一季度收购了Cingate的一个新头寸,价值10万美元。最后,创意策划在第二季度获得了一个价值3.4万美元的新职位。机构投资者和对冲基金持有该公司2.35%的股票。
关于扣带
(获取评级)
Cingate Inc.是一家临床阶段的生物制药公司,专注于开发治疗注意力缺陷/多动障碍的候选产品。该公司的主要候选产品是处于第三阶段临床试验的CTX-1301(醋酸地塞米酯)和用于治疗注意力缺陷/多动障碍的CTX-1302(右旋苯丙胺)。
阅读更多内容
- 免费获取StockNews.com关于Cingate的研究报告(CING)
- 2023年3家航空公司股票腾飞
- 华尔街为何看好Target Stock
- 梅西百货的指导对零售业意味着什么
- Fortinet股价起伏不定,原因如下
- 分析师评级后,Apexigen股票飙升,是时候买入了吗?
接受《扣带日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Cingate及相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧